A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis.
A randomised, multicenter Phase III trial to evaluate the efficacy and safety of Polmacoxib compared with Celecoxib and Placebo for patients with osteoarthritis.